New Zealand Black (NZB) mice spontaneously produce anti-erythrocyte autoantibodies (AEA) in association with splenomegaly, thus serving as a model for autoimmune hemolytic anemia. Although these autoimmune traits are inherited as a dominant fashion, expression in F 1 hybrids of NZB and most non-New Zealand strains is suppressed due to the contribution of wild-type modifying genes present in the latter strains. Using chromosomal microsatellite markers in the (C57BL/6 ⍥ NZB)F 1 ⍥ NZB backcross progeny, we mapped C57BL/6 modifying loci for AEA production and splenomegaly. Generation of AEA was found to be down-regulated by a combined effect of two major independently segregating dominant alleles-one linked to D7MIT30 on chromosome 7 and the other linked to D10MIT42 on chromosome 10. Splenomegaly was modified mainly by a single C57BL/6 allele linked to D4MIT58 on chromosome 4. Thus, the autoimmune hemolytic anemia in the NZB strain is under multigenic control and a combined action of not only susceptibility but also modifying alleles with suppressive activities affects the outcome of disease features in the progeny. There are potentially important candidate genes which may be linked to the regulation of AEA and splenomegaly.
Introduction
The New Zealand Black (NZB) strain of mouse spontaneously hyperplasia and over-disposal of sensitized erythrocytes, has also been reported to be under multigenic control (10) . develops autoimmune hemolytic anemia, in association with anti-erythrocyte autoantibodies (AEA), decreases in hematoGenetic studies using crosses of NZB and non-autoimmune New Zealand Chocolate (NZC) mouse strains revealed that crit values, reticulocytosis, hemoglobinemia and splenomegaly, thus resembling the human counterpart of the disease 100% of (NZBϫNZC)F 1 and 74% of the F 2 hybrids developed positive AEA (1,4), a finding consistent with the notion that a (1-3). Earlier studies using crosses of NZB and other strains suggested that the AEA production is under multigenic control single dominant gene may control AEA. However, later studies demonstrated that F 1 hybrids of NZB and non-autoimmune, (4) (5) (6) (7) (8) (9) . Splenomegaly, which may be caused by both lymphoid Fig. 1 . Expression of the two autoimmune traits, AEA production (a) and splenomegaly (b) in NZB, C57BL/6 (B6), (C57BL/6ϫNZB)F 1 (F 1 ) and (C57BL/6ϫNZB)F 1 ϫNZB backcross (B.C.) mice. Mice were scored for the onset of AEA production as described in Methods (a). Spleen sizes were measured at the time of killing at 13 months of Fig. 2 . Association of the two autoimmune traits, production of AEA age (b) .
and splenomegaly in female progeny of the (C57BL/6ϫNZB)F 1 ϫNZB backcross mice. AEA scores of individual mice were determined by the earliest age (month) when macroscopically visible agglutination of erythrocyte was detected in direct Coombs' test (see Methods).
non-New Zealand mouse strains had a much lower incidence
Mice with spleens over 300 mg were regarded as having and a later onset of positive AEA (5-7). These findings were splenomegaly.
interpreted, as a hypothetical model, that the NZB strain contributes a single dominant susceptibility allele Aia-1 (autoimmune anemia locus) loosely linked to the b locus of chromosome 4 (4) to the full expression of production of AEA, 7.2. Aliquots of 50 µl of 4% erythrocytes suspensions were whereas the effect of this gene is suppressed to a varying incubated with 50 µl of the 1:16 diluted rabbit anti-mouse Ig degree by wild-type modifying dominant alleles present in sera in test tubes for 30 min at room temperature and the most strains of mice, except for NZB and NZC (6,9), one of mixture was then gently centrifuged. Macroscopically visible which (Aem-1, anti-erythrocyte autoantibody modifying gene) agglutination was regarded as a positive AEA. All mice 6-was mapped to the locus loosely linked to the Mup-1 on 13 months of age were examined monthly. Onset of AEA chromosome 4 (9) . production in an individual mouse was scored, based on the Thus, it appears that the autoimmune hemolytic anemia in earliest month of age when positive AEA was detected. AEA the NZB strain is regulated by a combined action of not only score (S) was defined as S ϭ -x ϩ 14, in which x is the age susceptibility but also modifying alleles with suppressive (months) of onset of positive AEA. Thus, the highest score activity. Nonetheless, classic progeny studies have provided (S ϭ 8) was given to mice that showed earliest onset (6 only limited information on the number, identity and chromomonths of age) and the lowest score (S ϭ 1) to mice of the somal location of the quantitative trait loci (QTL) for multigenic most delayed (13 months of age) onset. Mice negative for diseases. Taking advantage of genome-wide analysis with AEA up to 13 months of age were scored as 0. microsatellite-based chromosomal maps (11), we mapped modifying alleles regulating the onset of AEA production Genotyping of chromosomal microsatellite markers and severity of splenomegaly, using (C57BL/6ϫNZB)F 1 ϫNZB Genomic DNA was extracted from liver tissues of mice that backcross mice.
have been stored at -70°C before use, as described (13). Polymorphisms of microsatellite markers were analyzed using the modified method described by Dietrich et al. (11) PCR Methods primers flanking chromosomal microsatellite markers Mice (MapPair primers) were purchased from Research Genetics (Huntsville, AL). A sulfhydryl group (SH) was introduced at NZB, C57BL/6 and their F 1 mice were derived from colonies housed at Juntendo University. Female (C57BL/6ϫNZB)F 1 the 5Ј site of one of the PCR primer pair, using T4 polynucleotide kinase and γ-S-ATP, and was subsequently reacted with mice at 2 months of age were crossed to male NZB mice to obtain (C57BL/6ϫNZB)F 1 ϫNZB backcross mice. Only female N-iodoacetyl-NЈ-biotinylhexylenediamine, using an oligonucleotide biotin labeling kit (US Biochemical, Cleveland, backcross mice were analyzed. OH). A PCR mixture (10 µl) contained 0.12 µM of one primer Test for AEA (biotin labeled), 0.12 µM of another primer (unlabeled), 0.25 mM of each dNTP, 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 Production of IgG AEA was examined by direct Coombs' test (12). Heparinized blood was obtained from the tail vein and mM MgCl 2 , 1.3 µg/ml of DNA and 0.05 U/µl of Taq polymerase (Takara Shuzo, Kyoto, Japan), followed by overlay with mineral erythrocytes were washed 4 times with isotonic PBS, pH oil (14). The PCR amplifications were carried out using a DNA 72°C for 10 min. PCR products were diluted 4-fold with loading buffer consisting of xylene cyanol and bromophenol thermal cycler (Perkin-Elmer Cetus, Foster City, CA). The reaction consisted of initial denaturation at 94°C for 1 min, blue dyes (each 0.5%) in formamide (95%) containing 10 mM of EDTA (pH 8.0), denatured at 94°C for 10 min, and followed by 30 cycles of 94°C for 1 min, 56-58°C for 1.5 min and 72°C for 2 min, and finally followed by a single cycle of electrophoresed on 6% denaturing polyacrylamide gels Symbols 'B' and 'N' depict NZB/C57BL/6 heterozygous and NZB/ NZB homozygous genotypes respectively. Scores of AEA production are expressed by means and SD. Significant differences are shown by asterisks (*P Ͻ 0.05, ** P Ͻ 0.01, *** P Ͻ 0.001, **** P Ͻ 0.0001).
buffer), and subsequently soaked in 0.125 mM CSPD (chemiluminescent substrate for phosphatases) (Boehringer) in assay buffer at 37°C for 5 min (15). The membrane with CSPD was sealed in a 'Hybridization Bag' (Cosmo Bio, Tokyo, Japan) and the chemiluminescent image was obtained by exposure of the membrane to Kodak X-OMAT AR film.
Data analysis
Linkage analyses were done using both Pearson's χ 2 test and interval mapping. Genomic interval mapping was done using a MAPMAKER/EXP and MAPMAKER/QTL software (16,17), (Fig. 1a) and spleen weights (Fig. 1b) of NZB, C57BL/6, (C57BL/6ϫNZB)F 1 and (C57BL/ incubated with streptavidin-alkaline phosphatase conjugate (Boehringer Mannheim, Mannheim, Germany) at 37°C for 5 6ϫNZB)F 1 ϫNZB backcross mice at 13 months of age. Observed incidences of AEA (AEA scores ജ1) in NZB, C57BL/ min. After extensive washings with 500 mM Tris-HCl (pH 9.5) containing 500 mM NaCl and 50 mM MgCl 2 , the membrane 6, their F 1 and the F 1 ϫNZB backcross mice were 100, 0, 0 and 61%, and those of splenomegaly (spleen weights Ͼ300 was soaked once in 0.1 mM diethanolamine (pH 10.0) containing 1.0 mM MgCl 2 and 0.02 % sodium azide (assay mg) were 86, 0, 0 and 48%, respectively.
autoimmune traits appear to function in a quantitative rather than all-or-none fashion (Figs 1 and 2) .
Mapping of modifying genes
To map the chromosomal loci for the regulation of AEA and splenomegaly, (C57BL/6ϫNZB)F 1 ϫNZB backcross mice were genotyped for 60 chromosomal microsatellite markers polymorphic between C57BL/6 and NZB strains (Fig. 3) . Chisquare analyses of associations between incidences of these two autoimmune traits and microsatellites showed the presence of two potential C57BL/6 suppressive loci for AEA on chromosomes 7 and 10 [as a potential modifying locus on chromosome 4 was designated Aem-1 in our earlier studies (9), these two were provisionally designated Aem-2 and Aem-3 respectively; anti-erythrocyte autoantibody modifier, for convenience to describe the interaction of modifying alleles], and one locus for splenomegaly on chromosome 4 (Spm-1, splenomegaly modifier-1) ( Table 1 ). Interval mapping of data from backcross mice at 13 months of age, using MAPMAKER/QTL, showed that the locus for Aem-2 on chromosome 7 is located between microsatellite markers D7MIT30 and D7MIT297 (Lod score ϭ 3.1, suggestive linkage) (Fig.  4) . On the other hand, the Lod score of another potential locus Aem-3 on chromosome 10, which was significantly linked to a marker D10MIT42, by using χ 2 analysis, was not in the range of significant associations (data not shown). However, the existence of Aem-3 was suggested by ANOVA, as based on data from the backcross progeny, classified according to the combinations of genotypes for D7MIT30 and D10MIT42, i.e. Group A, NZB/NZB (NN) genotype for both D7MIT30 and D10MIT42 loci; Group B, NZB type for D7MIT30 and C57BL/6 type for D10MIT42 (NB); Group C, C57BL/6 type for D7MIT30 and NZB type for D10MIT42 (BN); and Group D, C57BL/6 type for both loci (BB) (Fig. 5 ). Among these four groups, the highest AEA scores (earliest onset) were observed in mice of Group A and the lowest in mice of Group D. Data on mice of Groups B and C were in between, indicating that the suppressive effects for AEA production 6 genotype for both loci) was compared with either Group C or Group B. Thus, it is reasonable to assume that the suppressive effect can be attributed to combined effects of
Association of AEA and splenomegaly in (C57BL/6ϫ
Aem-2 and Aem-3. NZB)F 1 ϫNZB backcross mice Figure 6 also shows the result of MAPMAKER/QTL scan for the C57BL/6 locus responsible for the suppression of A total 75 female progeny of (C57BL/6ϫNZB)F 1 ϫNZB backcross mice were examined to determine the association splenomegaly on chromosome 4. The peak QTL was located most proximal to D4MIT58 (Lod score ϭ 3.6, significant between AEA scores and spleen weights at 13 months of age (Fig. 2) . AEA scores and spleen weights overall showed linkage). a low but a significant association (r ϭ 0.327, P Ͻ 0.005). However, there were backcross mice that were positive for Discussion AEA (AEA scores ജ1) and negative for splenomegaly, or vice versa, suggesting that these two autoimmune traits are not At least two potential C57BL/6 loci probably function in a suppressive manner for the onset of AEA in NZB mice: one under identical genetic control. Compared to the parental NZB strain (AEA scores ജ4), a proportion of backcross mice Aem-2 was located proximal to the marker D7MIT30 on chromosome 7 and the other Aem-3 proximal to D10MIT42 showed delayed onsets of AEA (AEA scores Ͻ4) and lower grades of splenomegaly findings which suggested that the on chromosome 10. While the association of locus Aem-2 was significant in both χ 2 and QTL scan analyses, the second suppressive effects of C57BL/6 modifying alleles for the two locus Aem-3 was only significant by χ 2 and not by QTL scan 1 is diluted or overridden by the effects of Aem-2 and/or Aem-3 in the present progeny studies. analyses. However, as the backcross progeny bearing both Aem-2 and Aem-3 showed a significantly late onset of AEA On the other hand, splenomegaly was significantly regulated by a C57BL/6 allele Spm-1 proximal to a microsatellite than was found in the progeny with either allele, Aem-3 appears to act in a combined manner with Aem-2 to suppress D4MIT58~30 cM telomeric to the Mup-1 locus on chromosome 4. In early studies using recombinant inbred strains AEA. It is of note, in this respect, that the insulin-like growth factor receptor gene igf-1r is located close to Aem-2 on derived from (ALNϫNZB)F 2 or (NFSϫNZB)F 2 mice, Raveche et al. (10) suggested that at least two genes (one dominant chromosome 7 (19) and the insulin-like growth factor-1 gene igf-1 to Aem-3 on chromosome 10 (20) . These genes require and the other recessive) are involved in the splenomegaly in NZB mice and which is associated with chromosomal study, because insulin-like growth factor is involved in the regulation of the transforming growth factor-β activity that is hyperdiploidy. Thus, it appears that C57BL/6 Spm-1 may be the wild-type allele of the NZB recessive gene that Raveche responsible for the negative regulation of immune responses (21) . Studies on polymorphisms and functions of igf-1 and et al. (10) proposed. Also, the genotype distribution we noted strongly suggests that Spm-1 is the wild-type allele of NZB igf-1r and the relation to the regulation of AEA production are underway in our laboratories.
splenomegaly gene Sbw2 on chromosome 4, as reported by Kono et al. (22) , which exhibited incomplete dominant In earlier studies, we found that a dominant suppressive locus Aem-1, loosely linked to Mup-1 on chromosome 4, is inheritance in (NZBϫNZW)F 2 intercross mice. There is the possibility that Spm-1/Sbw2 and Aem-1 are a single polyinvolved in the regulation of AEA production (9) . In the present studies, there were no microsatellites on chromosome 4 which morphic gene and contribute to the regulation of both splenomegaly and AEA, because AEA scores and spleen weights showed a significant association with the observed AEA regulation. It may be that chromosomal intervals between overall showed a significant association in the backcross progeny (Fig. 2) . Our preliminary observation supports this Aem-1 and the microsatellites used in the present studies are not close enough to show significant linkages. Alternatively, idea in that the backcross progeny bearing C57BL/6 genotypes at both microsatellites D4MIT58 (linked to Spm-1) and it may be due to the difference in evaluation of the disease trait in which the associations in earlier studies were analyzed D7MIT30 (linked to Aem-2) showed lower serum levels of AEA in later life than did the progeny with either one of the based on the presence or absence of AEA irrespective of age, while the present analyses were made based on the genotype (data not shown). Further studies are required to confirm this issue. The role of Spm-1/Sbw2 is unclear, but is time of AEA onset in order to evaluate the disease feature as a quantitative trait. It is also possible that the effect of Aemmost likely related to lymphocyte activation and hyperplasia.
patients with either cancer or viral hepatitis (25, 26) . In addition to the above loci, previous genetic studies of Abbreviations autoimmune disease-prone mice mapped several autoimmune traits to loci on chromosome 4 (summarized in Fig.   AEA anti-erythrocyte autoantibody 7 
